STABILIZED PRE-FUSION RSV FB ANTIGENS

The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV inf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LANGEDIJK Johannes Petrus Maria, BAKKERS Mark Johannes Gerardus, RITSCHEL Tina
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LANGEDIJK Johannes Petrus Maria
BAKKERS Mark Johannes Gerardus
RITSCHEL Tina
description The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV infection. La presente invención proporciona proteínas FB del virus respiratorio sincitial (RSV) prefusión estables, moléculas de ácido nucleico y vectores que codifican tales proteínas, y composiciones que comprenden tales proteínas, moléculas y/o vectores de ácido nucleico, y usos de estas para la prevención y/o tratamiento de la infección por RSV.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2023009738A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2023009738A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2023009738A3</originalsourceid><addsrcrecordid>eNrjZFANDnF08vTxjHJ1UQgIctV1Cw329PdTCAoOU3BzUnD0C_F0d_UL5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgZGxgYGlubGFo7GRCkCAOZSI8k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABILIZED PRE-FUSION RSV FB ANTIGENS</title><source>esp@cenet</source><creator>LANGEDIJK Johannes Petrus Maria ; BAKKERS Mark Johannes Gerardus ; RITSCHEL Tina</creator><creatorcontrib>LANGEDIJK Johannes Petrus Maria ; BAKKERS Mark Johannes Gerardus ; RITSCHEL Tina</creatorcontrib><description>The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV infection. La presente invención proporciona proteínas FB del virus respiratorio sincitial (RSV) prefusión estables, moléculas de ácido nucleico y vectores que codifican tales proteínas, y composiciones que comprenden tales proteínas, moléculas y/o vectores de ácido nucleico, y usos de estas para la prevención y/o tratamiento de la infección por RSV.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230830&amp;DB=EPODOC&amp;CC=MX&amp;NR=2023009738A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230830&amp;DB=EPODOC&amp;CC=MX&amp;NR=2023009738A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LANGEDIJK Johannes Petrus Maria</creatorcontrib><creatorcontrib>BAKKERS Mark Johannes Gerardus</creatorcontrib><creatorcontrib>RITSCHEL Tina</creatorcontrib><title>STABILIZED PRE-FUSION RSV FB ANTIGENS</title><description>The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV infection. La presente invención proporciona proteínas FB del virus respiratorio sincitial (RSV) prefusión estables, moléculas de ácido nucleico y vectores que codifican tales proteínas, y composiciones que comprenden tales proteínas, moléculas y/o vectores de ácido nucleico, y usos de estas para la prevención y/o tratamiento de la infección por RSV.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFANDnF08vTxjHJ1UQgIctV1Cw329PdTCAoOU3BzUnD0C_F0d_UL5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgZGxgYGlubGFo7GRCkCAOZSI8k</recordid><startdate>20230830</startdate><enddate>20230830</enddate><creator>LANGEDIJK Johannes Petrus Maria</creator><creator>BAKKERS Mark Johannes Gerardus</creator><creator>RITSCHEL Tina</creator><scope>EVB</scope></search><sort><creationdate>20230830</creationdate><title>STABILIZED PRE-FUSION RSV FB ANTIGENS</title><author>LANGEDIJK Johannes Petrus Maria ; BAKKERS Mark Johannes Gerardus ; RITSCHEL Tina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2023009738A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LANGEDIJK Johannes Petrus Maria</creatorcontrib><creatorcontrib>BAKKERS Mark Johannes Gerardus</creatorcontrib><creatorcontrib>RITSCHEL Tina</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LANGEDIJK Johannes Petrus Maria</au><au>BAKKERS Mark Johannes Gerardus</au><au>RITSCHEL Tina</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABILIZED PRE-FUSION RSV FB ANTIGENS</title><date>2023-08-30</date><risdate>2023</risdate><abstract>The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV infection. La presente invención proporciona proteínas FB del virus respiratorio sincitial (RSV) prefusión estables, moléculas de ácido nucleico y vectores que codifican tales proteínas, y composiciones que comprenden tales proteínas, moléculas y/o vectores de ácido nucleico, y usos de estas para la prevención y/o tratamiento de la infección por RSV.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2023009738A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title STABILIZED PRE-FUSION RSV FB ANTIGENS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LANGEDIJK%20Johannes%20Petrus%20Maria&rft.date=2023-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2023009738A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true